U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07489729) titled 'Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer' on March 18.
Brief Summary: The aim of the study is
1. Statistical evaluation of patients' characteristics who have intermediate & high risk localized prostate cancer.
2. Statistical analysis of treatment efficacy of combined hormonal therapy & hypo fractionated intensity modulated radiotherapy compared with conventionally fractionated radiotherapy plus hormonal treatment as regard biochemical failure, disease free survival & overall survival.
3. Evaluation of acute as well as late toxic side effects after radiotherapy.
Study ...